{rfName}

Indexed in

License and use

Altmetrics

Grant support

The PREDIMED-Plus trial was supported by the Spanish government's official funding agency for biomedical research, ISCIII, through the Fondo de Investigacion para la Salud (FIS) and co-funded by European Union ERDF/ESF, A way to make Europe/Investing in your future (five coordinated FIS projects led by JS-S and JVid, including the following project PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560 and PI19/01332), the Special Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad fisica Cohorte PREDIMED-Plus grant to JS-S, the European Research Council (Advanced Research Grant 2013-2018, 340918) to MAM-G, the Recercaixa Grant to JS-S (2013ACUP00194), grants from the Consejeria de Salud de la Junta de Andalucia (PI0458/2013, PS0358/2016 and PI0137/2018), a grant from the Generalitat Valenciana (PROMETEO/2017/017), a SEMERGEN grant, and funds from the European Regional Development Fund (CB06/03). This research was also partially funded by EU-H2020 Grant (EAT2BENICE/H2020-SFS-2016-2; Ref 728018). Study resulting from the SLT006/17/00246 grant was funded by the Department of Health of the Generalitat de Catalunya by the call Accio instrumental de programes de recerca orientats en l'ambit de la recerca i la innovacio en salut. We thank CERCA Programme/Generalitat de Catalunya for institutional support. This work is partially supported by ICREA under the ICREA Academia program. IP-G receives a grant from the Spanish Ministry of Education, Culture and Sports (FPU 17/01925). L.C.-B. is the recipient of a predoctoral fellowship from the Generalitat de Catalunya's Department of Universities (FI-DGR 2017). NB-T is supported by a postdoctoral fellowship (Juan de la Cierva-Formacion, FJC2018-036016-I) MRBL was supported by Miguel Servet Type I program (CP15/00028) from the ISCIII-Madrid (Spain), cofinanced by the Fondo Europeo de Desarrollo Regional-FEDER.

Share

November 3, 2020
Publications
>
Article
No

Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population

Publicated to:European Journal Of Nutrition. 60 (5): 2381-2396 - 2021-08-01 60(5), DOI: 10.1007/s00394-020-02415-w

Authors: Paz-Graniel, Indira; Babio, Nancy; Becerra-Tomas, Nerea; Toledo, Estefania; Camacho-Barcia, Lucia; Corella, Dolores; Castaner-Nino, Olga; Romaguera, Dora; Vioque, Jesus; Alonso-Gomez, Angel M; Warnberg, Julia; Martinez, J Alfredo; Serra-Majem, Luis; Estruch, Ramon; Tinahones, Francisco J; Fernandez-Aranda, Fernando; Lapetra, Jose; Pinto, Xavier; Tur, Josep A; Garcia-Rios, Antonio; Bueno-Cavanillas, Aurora; Gaforio, Jose J; Matia-Martin, Pilar; Daimiel, Lidia; Sanchez, Vicente Martin; Vidal, Josep; Prieto-Sanchez, Lucia; Ros, Emilio; Razquin, Cristina; Mestres, Cristina; Sorli, Jose V; Cuenca-Royo, Aida M; Rios, Angel; Torres-Collado, Laura; Vaquero-Luna, Jessica; Perez-Farinos, Napoleon; Zulet, M Angeles; Sanchez-Villegas, Almudena; Casas, Rosa; Bernal-Lopez, M Rosa; Santos-Lozano, Jose Manuel; Corbella, Xavier; Mateos, David; Buil-Cosiales, Pilar; Jimenez-Murcia, Susana; Fernandez-Carrion, Rebeca; Forcano-Gamazo, Laura; Lopez, Meritxell; Sempere-Pascual, Miguel Angel; Moreno-Rodriguez, Anai; Gea, Alfredo; De la Torre-Fornell, Rafael; Salas-Salvado, Jordi

Affiliations

August Pi & Sunyer Biomed Res Inst IDIBAPS, Hosp Clin, Dept Endocrinol & Nutr, Lipid Clin, Barcelona, Spain - Author
Bellvitge Univ Hosp, IDIBELL, Dept Psychiat, Barcelona, Spain - Author
Bellvitge Univ Hosp, Internal Med, Lipids & Vasc Risk Unit, Barcelona, Spain - Author
Carlos III Hlth Inst ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain - Author
Carlos III Hlth Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain - Author
Carlos III Hlth Inst, CIBER Physiol Obes & Nutr CIBEROBN, Madrid, Spain - Author
CSIC, Nutr Genom & Epigen Grp, IMDEA Food, CEI UAM, Madrid, Spain - Author
Distrito Sanitario Atenc Primaria Sevilla, Dept Family Med, Res Unit, Seville, Spain - Author
Fdn Jimenez Diaz, Dept Endocrinol, Madrid, Spain - Author
Horts Miro Hlth Ctr, Reus, Spain - Author
Hosp del Mar Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain - Author
Hosp del Mar Res Inst IMIM, Integrat Pharmacol & Syst Neurosci FINS, Barcelona, Spain - Author
Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain - Author
Joan XXIII Univ Hosp, Tarragona, Spain - Author
Miguel Hernandez Univ, ISABIAL UMH, Alicante, Spain - Author
Reg Univ Hosp Malaga, Inst Invest Biomed Malaga IBIMA, Internal Med Dept, Malaga, Spain - Author
Rovira & Virgili Univ, Dept Biochem & Biotechnol, Human Nutr Unit, Reus, Spain - Author
San Carlos Clin Hosp IdISSC, Hlth Res Inst, Dept Endocrinol & Nutr, Madrid, Spain - Author
Sant Joan Univ Hosp, Human Nutr Unit, Reus, Spain - Author
Santa Pola Hlth Ctr, Alicante, Spain - Author
Univ Balear Islands, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain - Author
Univ Barcelona, August Pi & Sunyer Biomed Res Inst IDIBAPS, Hosp Clin, Dept Endocrinol, Barcelona, Spain - Author
Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Dept Internal Med, Barcelona, Spain - Author
Univ Basque Country UPV EHU, Araba Univ Hosp, Bioaraba Hlth Res Inst, Osakidetza Basque Hlth Serv, Vitoria, Spain - Author
Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Internal Med, Cordoba, Spain - Author
Univ Granada, Dept Prevent Med, Granada, Spain - Author
Univ Hosp Son Espases, Hlth Res Inst Balear Islands IdISBa, Palma De Mallorca, Spain - Author
Univ Int Catalunya, Med & Hlth Sci Fac, Barcelona, Spain - Author
Univ Jaen, Dept Ciencias Salud, Ctr Estudios Avanzados Olivar & Aceites Oliva, Jaen, Spain - Author
Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci IUIBS, Ctr Hosp Univ Insular Materno Infantil CHUIMI, Prevent Med Serv,Canarian Hlth Serv, Las Palmas Gran Canaria, Spain - Author
Univ Leon, Inst Biomed IBIOMED, Leon, Spain - Author
Univ Malaga, Sch Hlth Sci, Dept Nursing, Inst Invest Biomed Malaga IBIMA, Malaga, Spain - Author
Univ Malaga, Sch Med, Dept Publ Hlth, Biomed Res Inst Malaga IBIMA, Malaga, Spain - Author
Univ Malaga, Virgen Victoria Hosp, Dept Endocrinol, Biomed Res Inst Malaga IBIMA, Malaga, Spain - Author
Univ Navarra, Dept Nutr Food Sci & Physiol, IDISNA, Pamplona, Spain - Author
Univ Navarra, Dept Prevent Med & Publ Hlth, IdisNA, Pamplona, Spain - Author
Univ Navarra, Fac Pharm & Nutr, Ctr Nutr Res, Pamplona, Spain - Author
Univ Valencia, Dept Prevent Med, Valencia, Spain - Author
Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia 46010, Spain - Author
See more

Abstract

Coffee is rich in compounds such as polyphenols, caffeine, diterpenes, melanoidins and trigonelline, which can stimulate brain activity. Therefore, the possible association of coffee consumption with cognition is of considerable research interest. In this paper, we assess the association of coffee consumption and total dietary caffeine intake with the risk of poor cognitive functioning in a population of elderly overweight/obese adults with metabolic syndrome (MetS).PREDIMED-plus study participants who completed the Mini-Mental State Examination test (MMSE) (n?=?6427; mean age?=?65?±?5 years) or a battery of neuropsychological tests were included in this cross-sectional analysis. Coffee consumption and total dietary caffeine intake were assessed at baseline using a food frequency questionnaire. Logistic regression models were fitted to evaluate the association between total, caffeinated and decaffeinated coffee consumption or total dietary caffeine intake and cognitive impairment.Total coffee consumers and caffeinated coffee consumers had better cognitive functioning than non-consumers when measured by the MMSE and after adjusting for potential confounders (OR 0.63; 95% CI 0.44-0.90 and OR 0.56; 95% CI 0.38-0.83, respectively). Results were similar when cognitive performance was measured using the Clock Drawing Test (CDT) and Trail Making Test B (TMT-B). These associations were not observed for decaffeinated coffee consumption. Participants in the highest tertile of total dietary caffeine intake had lower odds of poor cognitive functioning than those in the reference tertile when screened by the MMSE (OR 0.64; 95% CI 0.47-0.87) or other neurophysiological tests evaluating a variety of cognitive domains (i.e., CDT and TMT-A).Coffee consumption and total dietary caffeine intake were associated with better cognitive functioning as measured by various neuropsychological tests in a Mediterranean cohort of elderly individuals with MetS.ISRCTN89898870. Registration date: July 24, 2014.

Keywords

benefitscaffeinecoffeecomponentdementiadiseaseimpairmentmini-mental statemini-mental state examinationolderpredimed-plusriskvalidationAdultAgedBenefitsCaffeineCoffeeCognitionCognitive impairmentCohort studiesComponentCross-sectional studiesDementiaDiseaseHumansImpairmentMiddle agedMini-mental stateMini-mental state examinationOlderPhysical-activity questionnairePredimed-plusRiskRisk factorsValidation

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal European Journal Of Nutrition due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Medicine (Miscellaneous).

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 1.09. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 1.73 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 6.96 (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-16, the following number of citations:

  • WoS: 19
  • Scopus: 23
  • Europe PMC: 14

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-16:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 158.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 168 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 191.25.
  • The number of mentions on the social network Facebook: 2 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 49 (Altmetric).
  • The number of mentions in news outlets: 20 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Granada.